Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Janssen Returns Global Rights to Cusatuzumab to Argenx (2021-06-07)
argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced it will regain worldwide rights to its anti-CD70 antibody cusatuzumab from Cilag GmbH I...
Amyl Therapeutics Closes €18.3m Series A Financing (2021-06-03)
Funds will be used to advance amyloid fibrils specific ClariTY technology platform as a potential best-in-class therapy for patients with Amyloidosis Amyl Therapeutics (‘Amyl’), a preclinical stage biotechnology company developing its amyloid fibrils specific ...
Exscientia Appoints Joanne Xu from SoftBank Board Director (2021-06-03)
> Joanne Xu is a Partner at SoftBank Investment Advisers with more than 20 years of investing and consulting experience in Asia > Fatou Bintou Sagnang, a Partner with Mubadala, is also joining as a Board Observer Exscientia the clinical stage, Artificial In...
ImaginAb $12.8m Financing Led by Adage Capital & Cycad Group (2021-06-03)
Latest financing will advance the clinical development of its CD8 ImmunoPET agent and build on its market leading position. ImaginAb Inc, a leading biotechnology company focused on developing next generation radiopharmaceutical imaging and therapy agents, has ...
Stablix Launches with $63m Series A Led by Versant Ventures (2021-06-03)
--Versant Ventures leads investment in first-in-category company with targeted protein stabilization platform -- --Foundational know-how establishes leadership in the field-- Stablix Therapeutics, a biotechnology company pioneering the field of Targeted Pro...
Transine Therapeutics Closes Extended £9.1m Seed Funding (2021-06-02)
New Company emerges from stealth with potential ground-breaking mRNA therapeutic platform to increase protein expression Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP® pl...
MorphoSys to Acquire Constellation for $1.7b (2021-06-02)
> Accelerates Growth Strategy by Adding Two Mid- to Late-Stage Product Candidates: Pelabresib (CPI-0610) and CPI-0209 > Bolsters Position in Hematology-Oncology and Expands into Solid Tumors > Best-in-Class Combined Discovery and Development Capabilities Acc...
Gilde Healthcare: Joep Muijrers to Lead Public Investments (2021-06-02)
Seasoned investment expert in the life science sector with impressive track-record Gilde Healthcare, a specialized healthcare investor with €1.4 billion under management, today announced the appointment of Dr. Joep Muijrers to the investment team of its Ventur...
Cytiva Acquires German Scientific Software Maker GoSilico (2021-06-02)
> GoSilico's software creates “digital twins” of downstream processes and is increasingly used to enhance process development by simulation > More than 80% of mechanistic modelling users surveyed by Cytiva identified this as the future process development of chr...
Macrophage Pharma Promotes CSO Venkat Reddy to CEO (2021-06-01)
Executive leadership and strategic focus strengthened for sustained company development Macrophage Pharma Limited (‘MPL’), a company focused on the discovery and early stage development of highly novel small molecule therapeutics with the potential to transfor...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] No Content Marketing 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]